ArticleMikrochimica acta2025
Se(IV) mediated anisotropic etching of bare gold nanorods for mutant biomarker sensing by surface-enhanced electrochemiluminescence.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
We present a novel Se(IV)-mediated etching protocol to control the etching orientation and geometrical evolution of bare gold nanorods (AuNRs) and exploit it as a highly sensitive surface-enhanced electrochemiluminescence (ECL) sensor. The initial etching orientation was intimately governed by the concentrations of Se(IV) and cetyltrimethylammoniumbromide (CTAB). Interestingly, an extraordinary lateral etching was preferentially observed in the Se(IV)/KI/CTAB system, leading to the formation of quasi-rectangular AuNRs with increased aspect ratio. This etching process afforded clear geometrical transformation, enabling the efficient synthesis of cubic gold nanoparticles and quasi-rectangular nanorods with an enhanced electric-field enhancement factor. The etched AuNRs immobilized on a glassy-carbon electrode produced a markedly enhanced ECL signal 4.42-fold higher than that of the unetched AuNRs. A detection limit as low as 9.24 pM was achieved for the p53 biomarker carrying a codon-249 mutation. Moreover, the method yielded a lower selectivity factor than previously reported strategies, highlighting its high selectivity and potential for discriminating mutant p53 DNA. Our study significantly advanced current p53 sensor capabilities and highlighted the power of etched plasmonic metasurfaces for sensitive optical detection.
Indexed as
Identifiers
41175256What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.